Answer
The safety and efficacy of Ilumetri (tildrakizumab) in children and adolescents under 18 years have not yet been established, and no data are available.
Sources for this answer
- Ilumetri 100 mg solution for injection in pre-filled syringeAlmirall Limited · emc · SmPC §4.2 Posology and method of administration · Version 6Document updated
Sources checked